Capitulation_0 Posted - 1 day ago

$APGE also

MaverikIT Posted - 2 days ago

@IsabellaDC @net0trader $JANX $APGE

Pika_Capital Posted - 2 days ago

$APGE 160 watchers. This is perfect buyout candidate 😂 just saying

Pika_Capital Posted - 4 days ago

$APGE this could be next ARGX in 5 years. I'm sitting tight while they are moving things forward

LongtermZ94 Posted - 4 days ago

Wedbush Securities analyst on $APGE 'The company also plans to open an asthma cohort in the Ph 1b trial for APG808, and will open a Dupixent comparator arm in an upcoming trial of APG777 + APG990 (OX40L mAb) in AD. APGE narrowed initiation of a Ph 1 HV trial for APG333 (TSLP mAb), to YE:2024 (from late 2024/early 2025) Supporting data for APG777’s activity, APGE shared that ongoing PD follow-up indicates near complete inhibition of pSTAT6 and sustained TARC inhibition at 12 months following a single dose. We view these results as not only strengthening our base case scenario of matching lebrikizumab efficacy in the upcoming AD readout, but also supporting an upside scenario with greater efficacy due to higher drug exposure. APGE notes a Q12M annual dosing interval is now under consideration, which would create additional upside due to likely increased market uptake.' $APGE $QQQ

Quantumup Posted - 11/27/24

Guggenheim⬆️PT $APGE $110 was $95/reiterated Buy/Best Idea ⦿ Sees $APGE' devt strategy as rational/efficient, aimed@ developing mono/combo assets not only differentiated by dosing duration, but also w/ BIC/FIC pot ⦿ TH2 mkt $APGE 🎯g est to > 2X to $50B+ by '30 ⦿ Sees >100%⬆️over next 2yrs:

Doozio Posted - 11/09/24

$APGE INTA 🧠⏰♾️

Pika_Capital Posted - 11/08/24

$APGE pretty swift recovery

BioTrade2 Posted - 10/28/24

$APGE Let's go! Give me 75 by EOY!!

BioTrade2 Posted - 10/28/24

$APGE Stuck in this range, needs to break out. Still love this stock long term.

Stoxpo Posted - 10/25/24

Apogee Therapeutics’ APG777 Demonstrates Promising Longevity in Phase 1 Study, Ahead of Key 2025 Milestones https://stoxpo.com/index.php/2024/10/25/apogee-therapeutics-apg777-demonstrates-promising-longevity-in-phase-1-study-ahead-of-key-2025-milestones/ $APGE $QQQ

vjtweet Posted - 10/16/24

$APGE take off soon... has a starter position.

Americanbulls Posted - 10/11/24

$APGE the bull pattern is confirmed & a BUY signal is issued @ www.Americanbulls.com/SignalPage.aspx?lang=en&Ticker=APGE. Buy Level: 56.94 Target: 101.92

Doozio Posted - 10/08/24

$APGE da FUTUre of 🧠⏰ is NOW during 🧠⏰♾️. Barring a faatch 💣. Obviously

insiderbuyingselling Posted - 2 months ago

$APGE new insider selling: 40000 shares. http://insiderbuyingselling.com/?t=APGE

Americanbulls Posted - 2 months ago

$APGE may go up 79% if the bull pattern is confirmed. Check confirmation [75%] @ www.Americanbulls.com/SignalPage.aspx?lang=en&Ticker=APGE. Buy level:56.85.

Pika_Capital Posted - 09/30/24

$APGE my watchers theory checks out 😂 jk

Pika_Capital Posted - 09/20/24

$APGE beautiful action. So quiet here, this is what you need in bios. Less retail watchers, the better

StockInvest_us Posted - 09/20/24

Signal alert: $APGE - Overbought Trend Short (Overvalued) https://stockinvest.us/l/raqn1CGU3O

vjtweet Posted - 09/18/24

$APGE holding it for a while.. ready to move now.

Doozio Posted - 09/11/24

$APGE no faaaatch 💣 in 🧠⏰

vjtweet Posted - 08/29/24

$APGE holding a long position. To add more on clearing 50 level.

Doozio Posted - 08/29/24

$APGE no faatch 💣s in 🧠⏰?

Doozio Posted - 08/26/24

$APGE chop chop huckleberries no faatch 💣 n it’s 🧠⏰

StockInvest_us Posted - 08/21/24

Signal alert: $APGE - Overbought Trend Short (Overvalued) https://stockinvest.us/l/GFCsUtFWq1

vu_jade Posted - 08/19/24

$APGE great looking wedge

Pika_Capital Posted - 08/19/24

$APGE flying under the radar

RockyTSTH Posted - 08/19/24

$APGE Apogree Therapeutics shares are trading higher after the company announced its initiated dosing of its clinical trail for APG990.

Stock_Titan Posted - 08/19/24

$APGE Apogee Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of APG990, its Novel Half-Life Extended OX40L Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Diseases https://www.stocktitan.net/news/APGE/apogee-therapeutics-announces-first-participants-dosed-in-phase-1-kbtiahgqm7t1.html

DonCorleone77 Posted - 08/12/24

$APGE Apogee Therapeutics reports Q2 net loss $33.8M vs. $18.9M last year As of June 30 Apogee had cash, cash equivalents and marketable securities of $789.6M. Apogee expects that its existing cash will enable it to fund its current operating expenses into the Q1 of 2028. "The first half of this year has been marked with significant pipeline progress and a focus on further defining our strategy that will enable us to deliver on our goal of reshaping the standard of care for patients in I&I by developing treatments with potential best-in-class monotherapy and combination efficacy and improved dosing schedules," said Michael Henderson, CEO. "A key component of that strategy is combining several of our pipeline programs, including APG333, which is our newly added compound targeting TSLP. TSLP is a validated target with one compound approved for asthma without a biomarker requirement, and which has recent clinical data demonstrating potential for treatment of a broader respiratory disease population, including COPD. We have strategically built a unique portfolio of IL-13, IL-4Ralpha, OX40L and TLSP inhibitors that enable multiple combinations in dermatology and respiratory diseases with the potential for deeper and broader responses. With our continued execution of the pipeline, our expected milestones are on track and we have a strong cash position taking us into 2028. We look forward to discussing our programs and additional plans for combination approaches in further detail at our R&D Day in December this year."